Lumos Diagnostics entered into a new distribution agreement with Regional Health Care Group, a Henry Schein company in Australia and New Zealand, for its FebriDx point-of-care test.

The agreement marks an expansion of FebriDx distribution, leveraging RHCG’s extensive network in the region.

Lumos Diagnostics CEO Doug Ward and Henry Schein’s Mike Covey both expressed enthusiasm for the partnership, which aims to meet the growing demand among healthcare professionals.